Skip to main content
NCBI home page
Thorax logoLink to Thorax
editorial
. 1995 Feb;50(2):105–110. doi: 10.1136/thx.50.2.105

New perspectives on inhaled drug delivery and systemic bioactivity.

B J Lipworth
PMCID: PMC473885  PMID: 7701444

Full text

PDF
105

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bain B. M., Harrison G., Jenkins K. D., Pateman A. J., Shenoy E. V. A sensitive radioimmunoassay, incorporating solid-phase extraction, for fluticasone 17-propionate in plasma. J Pharm Biomed Anal. 1993 Jul;11(7):557–561. doi: 10.1016/0731-7085(93)80005-l. [DOI] [PubMed] [Google Scholar]
  2. Barnes N. C., Marone G., Di Maria G. U., Visser S., Utama I., Payne S. L. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group. Eur Respir J. 1993 Jun;6(6):877–885. [PubMed] [Google Scholar]
  3. Borgström L., Bondesson E., Morén F., Trofast E., Newman S. P. Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects. Eur Respir J. 1994 Jan;7(1):69–73. doi: 10.1183/09031936.94.07010069. [DOI] [PubMed] [Google Scholar]
  4. Borgström L., Newman S., Weisz A., Morén F. Pulmonary deposition of inhaled terbutaline: comparison of scanning gamma camera and urinary excretion methods. J Pharm Sci. 1992 Aug;81(8):753–755. doi: 10.1002/jps.2600810807. [DOI] [PubMed] [Google Scholar]
  5. Brown P. H., Blundell G., Greening A. P., Crompton G. K. Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax. 1990 Oct;45(10):736–739. doi: 10.1136/thx.45.10.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brown P. H., Greening A. P., Crompton G. K. Large volume spacer devices and the influence of high dose beclomethasone dipropionate on hypothalamo-pituitary-adrenal axis function. Thorax. 1993 Mar;48(3):233–238. doi: 10.1136/thx.48.3.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brown P. H., Matusiewicz S. P., Shearing C., Tibi L., Greening A. P., Crompton G. K. Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects. Thorax. 1993 Oct;48(10):967–973. doi: 10.1136/thx.48.10.967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Collier J. G., Dobbs R. J., Williams I. Salbutamol aerosol causes a tachycardia due to the inhaled rather than the swallowed fraction. Br J Clin Pharmacol. 1980 Mar;9(3):273–274. doi: 10.1111/j.1365-2125.1980.tb04837.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fabbri L., Burge P. S., Croonenborgh L., Warlies F., Weeke B., Ciaccia A., Parker C. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group. Thorax. 1993 Aug;48(8):817–823. doi: 10.1136/thx.48.8.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Geddes D. M. Inhaled corticosteroids: benefits and risks. Thorax. 1992 Jun;47(6):404–407. doi: 10.1136/thx.47.6.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Grahnén A., Eckernäs S. A., Brundin R. M., Ling-Andersson A. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Br J Clin Pharmacol. 1994 Dec;38(6):521–525. doi: 10.1111/j.1365-2125.1994.tb04393.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grove A., Allam C., McFarlane L. C., McPhate G., Jackson C. M., Lipworth B. J. A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects. Br J Clin Pharmacol. 1994 Dec;38(6):527–532. doi: 10.1111/j.1365-2125.1994.tb04394.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Harding S. M. The human pharmacology of fluticasone propionate. Respir Med. 1990 Nov;84 (Suppl A):25–29. doi: 10.1016/s0954-6111(08)80004-2. [DOI] [PubMed] [Google Scholar]
  14. Harding S. M. The human pharmacology of fluticasone propionate. Respir Med. 1990 Nov;84 (Suppl A):25–29. doi: 10.1016/s0954-6111(08)80004-2. [DOI] [PubMed] [Google Scholar]
  15. Hindle M., Chrystyn H. Determination of the relative bioavailability of salbutamol to the lung following inhalation. Br J Clin Pharmacol. 1992 Oct;34(4):311–315. doi: 10.1111/j.1365-2125.1992.tb05921.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Johansson S. A., Andersson K. E., Brattsand R., Gruvstad E., Hedner P. Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man. Eur J Clin Pharmacol. 1982;22(6):523–529. doi: 10.1007/BF00609625. [DOI] [PubMed] [Google Scholar]
  17. Küng M., Croley S. W., Phillips B. A. Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol. Influence of mouth rinsing and gargling. Chest. 1987 Mar;91(3):382–387. doi: 10.1378/chest.91.3.382. [DOI] [PubMed] [Google Scholar]
  18. Lipworth B. J., Clark R. A., Dhillon D. P., Moreland T. A., Struthers A. D., Clark G. A., McDevitt D. G. Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol. 1989;37(6):567–571. doi: 10.1007/BF00562546. [DOI] [PubMed] [Google Scholar]
  19. Lipworth B. J. Clinical pharmacology of corticosteroids in bronchial asthma. Pharmacol Ther. 1993;58(2):173–209. doi: 10.1016/0163-7258(93)90049-j. [DOI] [PubMed] [Google Scholar]
  20. Lipworth B. J., McDevitt D. G., Struthers A. D. Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects. Br J Clin Pharmacol. 1989 Jun;27(6):837–842. doi: 10.1111/j.1365-2125.1989.tb03447.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lipworth B. J., Newnham D. M., Clark R. A., Dhillon D. P., Winter J. H., McDevitt D. G. Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients. Thorax. 1995 Jan;50(1):54–61. doi: 10.1136/thx.50.1.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lipworth B. J. Risks versus benefits of inhaled beta 2-agonists in the management of asthma. Drug Saf. 1992 Jan-Feb;7(1):54–70. doi: 10.2165/00002018-199207010-00007. [DOI] [PubMed] [Google Scholar]
  23. Martin L. E., Harrison C., Tanner R. J. Metabolism of beclomethasone dipropionate by animals and man. Postgrad Med J. 1975;51 (Suppl 4):11–20. [PubMed] [Google Scholar]
  24. Melchor R., Biddiscombe M. F., Mak V. H., Short M. D., Spiro S. G. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax. 1993 May;48(5):506–511. doi: 10.1136/thx.48.5.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Monson J. P. Systemic effects of inhaled corticosteroids. Thorax. 1993 Oct;48(10):955–956. doi: 10.1136/thx.48.10.955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Morgan D. J., Paull J. D., Richmond B. H., Wilson-Evered E., Ziccone S. P. Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. Br J Clin Pharmacol. 1986 Nov;22(5):587–593. doi: 10.1111/j.1365-2125.1986.tb02939.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Motwani J. G., Lipworth B. J. Clinical pharmacokinetics of drug administered buccally and sublingually. Clin Pharmacokinet. 1991 Aug;21(2):83–94. doi: 10.2165/00003088-199121020-00001. [DOI] [PubMed] [Google Scholar]
  28. Newman S. P., Millar A. B., Lennard-Jones T. R., Morén F., Clarke S. W. Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax. 1984 Dec;39(12):935–941. doi: 10.1136/thx.39.12.935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Newman S. P., Weisz A. W., Talaee N., Clarke S. W. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax. 1991 Oct;46(10):712–716. doi: 10.1136/thx.46.10.712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Newnham D. M., Lipworth B. J. Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream"). Thorax. 1994 Aug;49(8):762–770. doi: 10.1136/thx.49.8.762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Newnham D. M., McDevitt D. G., Lipworth B. J. Comparison of the extrapulmonary beta2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered dose-inhaler and modified actuator device. Br J Clin Pharmacol. 1993 Nov;36(5):445–450. doi: 10.1111/j.1365-2125.1993.tb00393.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Newnham D. M., Wheeldon N. M., Lipworth B. J., McDevitt D. G. Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects. Thorax. 1993 Jun;48(6):656–658. doi: 10.1136/thx.48.6.656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Pedersen S., Steffensen G., Ohlsson S. V. The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler. Br J Clin Pharmacol. 1993 Sep;36(3):211–214. doi: 10.1111/j.1365-2125.1993.tb04219.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Phillipps G. H. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med. 1990 Nov;84 (Suppl A):19–23. doi: 10.1016/s0954-6111(08)80003-0. [DOI] [PubMed] [Google Scholar]
  35. Selroos O., Halme M. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler. Thorax. 1991 Dec;46(12):891–894. doi: 10.1136/thx.46.12.891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Toogood J. H., Baskerville J., Jennings B., Lefcoe N. M., Johansson S. A. Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am Rev Respir Dis. 1984 May;129(5):723–729. doi: 10.1164/arrd.1984.129.5.723. [DOI] [PubMed] [Google Scholar]
  37. Tønnesen F., Laursen L. C., Evald T., Ståhl E., Ibsen T. B. Bronchodilating effect of terbutaline powder in acute severe bronchial obstruction. Chest. 1994 Mar;105(3):697–700. doi: 10.1378/chest.105.3.697. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES